Invention Grant
US07718615B2 Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
有权
抗抑郁素（CN）及其用于预防转移和其他病症的方法
- Patent Title: Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
- Patent Title (中): 抗抑郁素（CN）及其用于预防转移和其他病症的方法
-
Application No.: US11544190Application Date: 2006-10-05
-
Publication No.: US07718615B2Publication Date: 2010-05-18
- Inventor: Francis S. Markland, Jr. , Matthew Ritter
- Applicant: Francis S. Markland, Jr. , Matthew Ritter
- Applicant Address: US CA Los Angeles
- Assignee: University of Southern California
- Current Assignee: University of Southern California
- Current Assignee Address: US CA Los Angeles
- Agency: Foley & Lardner LLP
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
Contortrostatin, a homodimeric disintegrin, modulates the adhesion, motility, and invasiveness of integrin expressing tumor cells. When formulated as a pharmaceutically acceptable composition, the proteins can be used to treat patients by inhibiting or disrupting disease processes associated with an integrin binding to an αvβ3 or αvβ5 integrin.
Public/Granted literature
- US20070123458A1 Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions Public/Granted day:2007-05-31
Information query
IPC分类:
